Monoallelic TP53-mutated CLL patients show durable response to ibrutinib monotherapy
PHILEMON: a step closer to using MRD to guide treatment decisions in mantle cell lymphoma (MCL)?
Carsten Niemann • 3 Dec 2016
Infections in patients receiving brentuximab vedotin or BTK inhibitors
Livio Pagano • 8 Mar 2021